Alisa Tubsuwan

25/25 Putthamonthol Road 4
Salaya, 73170, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Establishment of a human induced pluripotent stem cell line MUi036-A from healthy male CD34+ hematopoietic stem/progenitor cells.

Establishment of a human induced pluripotent stem cell line MUi036-A from healthy male CD34+ hematopoietic stem/progenitor cells.

Journal: Stem cell research

Published: April 03, 2026

Activation of farnesoid X receptor inhibits TMEM16A-mediated chloride secretion in renal collecting duct cells and retards renal cyst progression.

Activation of farnesoid X receptor inhibits TMEM16A-mediated chloride secretion in renal collecting duct cells and retards renal cyst progression.

Journal: American journal of physiology. Renal physiology

Published: February 27, 2026

AAV-mediated delivery of CRISPR/Cas9 targeting conserved overlapping ORFs efficiently suppresses HBV replication in hepatocyte models.

AAV-mediated delivery of CRISPR/Cas9 targeting conserved overlapping ORFs efficiently suppresses HBV replication in hepatocyte models.

Journal: Biotechnology reports (Amsterdam, Netherlands)

Published: December 24, 2025

Establishment of MURAi007-A, a human induced pluripotent stem cell line from a patient with inherited retinal dystrophy carrying compound heterozygous mutations in the PNPLA6 gene.

Establishment of MURAi007-A, a human induced pluripotent stem cell line from a patient with inherited retinal dystrophy carrying compound heterozygous mutations in the PNPLA6 gene.

Journal: Stem cell research

Published: October 21, 2025

A novel potent autophagy inhibitor HM-013 limits production of infectious dengue virus particles.

A novel potent autophagy inhibitor HM-013 limits production of infectious dengue virus particles.

Journal: Virology journal

Published: July 31, 2025

Generation of integration-free human induced pluripotent stem cell line MUi040-A derived from CD34 + hematopoietic stem cells of a patient with constitutional pericentric inversion of chromosome 9.

Generation of integration-free human induced pluripotent stem cell line MUi040-A derived from CD34 + hematopoietic stem cells of a patient with constitutional pericentric inversion of chromosome 9.

Journal: Stem cell research

Published: June 16, 2025

A pyrimido-indole derivative promotes the differentiation of hematopoietic stem and progenitor cells from human-induced pluripotent stem cells by modulating YAP/Hippo signaling pathway.

A pyrimido-indole derivative promotes the differentiation of hematopoietic stem and progenitor cells from human-induced pluripotent stem cells by modulating YAP/Hippo signaling pathway.

Journal: European journal of pharmacology

Published: January 31, 2025

Disrupting ZBTB7A or BCL11A binding sites reactivates fetal hemoglobin in erythroblasts from healthy and β0-thalassemia/HbE individuals.

Disrupting ZBTB7A or BCL11A binding sites reactivates fetal hemoglobin in erythroblasts from healthy and β0-thalassemia/HbE individuals.

Journal: Scientific reports

Published: January 21, 2025

Establishing of human induced pluripotent stem cell line DMSCi002-A from the hematopoietic stem cells of a healthy male donor.

Establishing of human induced pluripotent stem cell line DMSCi002-A from the hematopoietic stem cells of a healthy male donor.

Journal: Stem cell research

Published: November 14, 2024

Erythropoiesis and Gene Expression Analysis in Erythroid Progenitor Cells Derived from Patients with Hemoglobin H/Constant Spring Disease.

Erythropoiesis and Gene Expression Analysis in Erythroid Progenitor Cells Derived from Patients with Hemoglobin H/Constant Spring Disease.

Journal: International journal of molecular sciences

Published: September 12, 2024

Generation of human induced pluripotent stem cell (DMSCi001-A) line from hematopoietic stem cells of a healthy female donor.

Generation of human induced pluripotent stem cell (DMSCi001-A) line from hematopoietic stem cells of a healthy female donor.

Journal: Stem cell research

Published: July 16, 2024

Genetic modifications of EGLN1 reactivate HbF production in β0-thalassemia/HbE.

Genetic modifications of EGLN1 reactivate HbF production in β0-thalassemia/HbE.

Journal: Heliyon

Published: July 09, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026